3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
CNS
1
Conditions
Neoplasms
7
Leukemia, Myeloid, Acute
6
Carcinoma, Hepatocellular
6
Neoplasm Metastasis
5
Colorectal Neoplasms
5
Breast Neoplasms
5
Stomach Neoplasms
4
Rectal Neoplasms
4
Recurrence
3
Ovarian Neoplasms
3
Multiple Myeloma
3
Esophageal Squamous Cell Carcinoma
3
Carcinoma, Non-Small-Cell Lung
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Pancreatic Neoplasms
2
Nasopharyngeal Carcinoma
2
Hematologic Neoplasms
2
Cholangiocarcinoma
2
Biliary Tract Neoplasms
2
Acute Kidney Injury
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Thymoma
1
Thymic epithelial tumor
1
Squamous NSCLC
1
Squamous Cell Non-small Cell Lung Cancer
1
Small Cell Lung Carcinoma
1
Interventions
trametinib
1
dabrafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Not yet recruiting
×
Histiocytosis, Langerhans-Cell
×
Clear all
NCT07440290
2026-02-27
DETERMINE
Cancer Research UK
Phase 2/3
Not yet recruiting
30 enrolled